Prothena Corp PLC (PRTA)
14.44
+0.04
(+0.28%)
USD |
NASDAQ |
Nov 21, 16:00
14.75
+0.31
(+2.15%)
After-Hours: 20:00
Prothena Revenue (Quarterly): 0.97M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.97M |
| June 30, 2024 | 132.01M |
| March 31, 2024 | 0.05M |
| December 31, 2023 | 0.316M |
| September 30, 2023 | 84.87M |
| June 30, 2023 | 4.019M |
| March 31, 2023 | 2.169M |
| December 31, 2022 | 49.92M |
| September 30, 2022 | 1.517M |
| June 30, 2022 | 1.312M |
| March 31, 2022 | 1.153M |
| December 31, 2021 | 1.172M |
| September 30, 2021 | 139.17M |
| June 30, 2021 | 60.07M |
| March 31, 2021 | 0.16M |
| December 31, 2020 | 0.36M |
| September 30, 2020 | 0.157M |
| June 30, 2020 | 0.195M |
| March 31, 2020 | 0.141M |
| December 31, 2019 | 0.256M |
| September 30, 2019 | 0.205M |
| June 30, 2019 | 0.167M |
| March 31, 2019 | 0.186M |
| December 31, 2018 | 0.194M |
| September 30, 2018 | 0.255M |
| Date | Value |
|---|---|
| June 30, 2018 | 0.279M |
| March 31, 2018 | 0.227M |
| December 31, 2017 | 0.229M |
| September 30, 2017 | 0.219M |
| June 30, 2017 | 26.81M |
| March 31, 2017 | 0.259M |
| December 31, 2016 | 0.171M |
| September 30, 2016 | 0.286M |
| June 30, 2016 | 0.333M |
| March 31, 2016 | 0.265M |
| December 31, 2015 | 0.307M |
| September 30, 2015 | 0.429M |
| June 30, 2015 | 0.278M |
| March 31, 2015 | 0.593M |
| December 31, 2014 | 2.013M |
| September 30, 2014 | 1.486M |
| June 30, 2014 | 15.12M |
| March 31, 2014 | 32.23M |
| December 31, 2013 | 0.167M |
| September 30, 2013 | 0.171M |
| June 30, 2013 | 0.167M |
| March 31, 2013 | 0.171M |
| December 31, 2012 | 0.575M |
| September 30, 2012 | 0.944M |
| June 30, 2012 | 0.735M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.05M
Minimum
Mar 2024
139.17M
Maximum
Sep 2021
24.00M
Average
1.162M
Median
Revenue (Quarterly) Benchmarks
| Amarin Corp PLC | 42.30M |
| Jazz Pharmaceuticals PLC | 1.055B |
| Iterum Therapeutics PLC | -- |
| GH Research PLC | -- |
| Mural Oncology PLC | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -59.00M |
| Total Expenses (Quarterly) | 67.48M |
| EPS Diluted (Quarterly) | -1.10 |
| Enterprise Value | 257.74M |
| Profit Margin (Quarterly) | -6.08K% |
| Earnings Yield | -17.17% |
| Normalized Earnings Yield | -17.17 |